FDA 483 - NuVasive, Inc - March 14, 2014

An FDA inspection of NuVasive, Inc.'s Human Tissue Distribution Center in Memphis, TN, identified one observation. The firm failed to record and maintain storage temperatures for Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps), specifically Osteocel products, as required by their procedures.